Home > Balance Sheet > AUROBINDO PHARMA

AUROBINDO PHARMA
Contingent Liabilities

    Back to Balance Sheet
COMMUNITY POLL
for AUROBINDO PHARMA
Please provide your vote to see the results

AUROBINDO PHARMA Last 5 Year Contingent Liabilities History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Contingent Liabilities ₹311 Cr₹159 Cr₹158 Cr₹141 Cr₹146 Cr

What is the latest Contingent Liabilities ratio of AUROBINDO PHARMA ?

The latest Contingent Liabilities ratio of AUROBINDO PHARMA is ₹311 Cr based on Mar2024 Consolidated results.
Year Contingent Liabilities
Mar2024₹311 Cr
Mar2023₹159 Cr
Mar2022₹158 Cr
Mar2021₹141 Cr
Mar2020₹146 Cr

How is Contingent Liabilities of AUROBINDO PHARMA Trending?

Years Contingent Liabilities % Change
Mar2024 ₹311 Cr
96.39
Mar2023 ₹159 Cr
0.50
Mar2022 ₹158 Cr
12.01
Mar2021 ₹141 Cr
-3.53
Mar2020 ₹146 Cr -

Compare Contingent Liabilities of peers of AUROBINDO PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AUROBINDO PHARMA ₹81,001.3 Cr -0.1% -6.4% 63.5% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹438,418.0 Cr -1.2% -4.7% 58.1% Stock Analytics
DIVIS LABORATORIES ₹157,680.0 Cr 0.8% 7.1% 73.4% Stock Analytics
CIPLA ₹128,755.0 Cr 2.7% -2.8% 32.8% Stock Analytics
DR REDDYS LABORATORIES ₹108,720.0 Cr 2.3% -2.2% 20.9% Stock Analytics
ZYDUS LIFESCIENCES ₹100,120.0 Cr -0.7% -5.6% 69.2% Stock Analytics


AUROBINDO PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
AUROBINDO PHARMA

-0.1%

-6.4%

63.5%

SENSEX

0.6%

-0.8%

25.4%


You may also like the below Video Courses